Literature DB >> 17655673

A novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome.

Yoshiyasu Aizawa1, Kazuo Ueda, Fabiana Scornik, Jonathan M Cordeiro, Yuesheng Wu, Mayurika Desai, Alejandra Guerchicoff, Yasutoshi Nagata, Yoshito Iesaka, Akinori Kimura, Masayasu Hiraoka, Charles Antzelevitch.   

Abstract

INTRODUCTION: Long QT Syndrome (LQTS) is an inherited disorder characterized by prolonged QT intervals and life-threatening polymorphic ventricular tachyarrhythmias. LQT1 caused by KCNQ1 mutations is the most common form of LQTS. METHODS AND
RESULTS: Patients diagnosed with LQTS were screened for disease-associated mutations in KCNQ1, KCNH2, KCNE1, KCNE2, KCNJ2, and SCN5A. A novel mutation was identified in KCNQ1 caused by a three-base deletion at the position 824-826, predicting a deletion of phenylalanine at codon 275 in segment 5 of KCNQ1 (DeltaF275). Wild-type (WT) and DeltaF275-KCNQ1 constructs were generated and transiently transfected together with a KCNE1 construct in CHO-K1 cells to characterize the properties of the slowly activating delayed rectifier current (IKs) using conventional whole-cell patch-clamp techniques. Cells transfected with WT-KCNQ1 and KCNE1 (1:1.3 molar ratio) produced slowly activating outward current with the characteristics of IKs. Tail current density measured at -40 mV following a two-second step to +60 mV was 381.3 +/- 62.6 pA/pF (n = 11). Cells transfected with DeltaF275-KCNQ1 and KCNE1 exhibited essentially no current. (Tail current density: 0.8 +/- 2.1 pA/pF, n = 11, P = 0.00001 vs WT). Cotransfection of WT- and DeltaF275- KCNQ1 (50/50), along with KCNE1, produced little to no current (tail current density: 10.3 +/- 3.5 pA/pF, n = 11, P = 0.00001 vs WT alone), suggesting a potent dominant negative effect. Immunohistochemistry showed normal membrane trafficking of DeltaF275-KCNQ1.
CONCLUSION: Our data suggest that a DeltaF275 mutation in KCNQ1 is associated with a very potent dominant negative effect leading to an almost complete loss of function of IKs and that this defect underlies a LQT1 form of LQTS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655673      PMCID: PMC2085492          DOI: 10.1111/j.1540-8167.2007.00889.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  22 in total

1.  Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome.

Authors:  F Y Shalaby; P C Levesque; W P Yang; W A Little; M L Conder; T Jenkins-West; M A Blanar
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.

Authors:  L Zhang; K W Timothy; G M Vincent; M H Lehmann; J Fox; L C Giuli; J Shen; I Splawski; S G Priori; S J Compton; F Yanowitz; J Benhorin; A J Moss; P J Schwartz; J L Robinson; Q Wang; W Zareba; M T Keating; J A Towbin; C Napolitano; A Medina
Journal:  Circulation       Date:  2000-12-05       Impact factor: 29.690

3.  Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus.

Authors:  F Yamashita; M Horie; T Kubota; H Yoshida; Y Yumoto; A Kobori; T Ninomiya; Y Kono; T Haruna; K Tsuji; T Washizuka; M Takano; H Otani; S Sasayama; Y Aizawa
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

4.  Molecular analysis at the Harvey Ras-1 gene in patients with long QT syndrome.

Authors:  E Schulze-Bahr; W Haverkamp; H Wiebusch; H Schulte; M Hördt; M Borggrefe; G Breithardt; G Assmann; H Funke
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 5.  Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias.

Authors:  Robert S Kass; Arthur J Moss
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

6.  Truncated KCNQ1 mutant, A178fs/105, forms hetero-multimer channel with wild-type causing a dominant-negative suppression due to trafficking defect.

Authors:  Yoshiyasu Aizawa; Kazuo Ueda; Long-Mei Wu; Natsuko Inagaki; Takeharu Hayashi; Megumi Takahashi; Masaaki Ohta; Seiko Kawano; Yuji Hirano; Michio Yasunami; Yoshifusa Aizawa; Akinori Kimura; Masayasu Hiraoka
Journal:  FEBS Lett       Date:  2004-09-10       Impact factor: 4.124

7.  New KCNQ1 mutations leading to haploinsufficiency in a general population; Defective trafficking of a KvLQT1 mutant.

Authors:  Laetitia Gouas; Chloe Bellocq; Myriam Berthet; Franck Potet; Sophie Demolombe; Anne Forhan; Rachel Lescasse; Françoise Simon; Beverley Balkau; Isabelle Denjoy; Bernard Hainque; Isabelle Baró; Pascale Guicheney
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

8.  A structural requirement for processing the cardiac K+ channel KCNQ1.

Authors:  Hideaki Kanki; Sabina Kupershmidt; Tao Yang; Sam Wells; Dan M Roden
Journal:  J Biol Chem       Date:  2004-05-12       Impact factor: 5.157

9.  ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome.

Authors:  A J Moss; W Zareba; J Benhorin; E H Locati; W J Hall; J L Robinson; P J Schwartz; J A Towbin; G M Vincent; M H Lehmann
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

10.  Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene.

Authors:  Elon C Roti Roti; Cena D Myers; Rebecca A Ayers; Dorothy E Boatman; Samantha A Delfosse; Edward K L Chan; Michael J Ackerman; Craig T January; Gail A Robertson
Journal:  J Biol Chem       Date:  2002-09-20       Impact factor: 5.157

View more
  8 in total

1.  Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant.

Authors:  Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

2.  Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.

Authors:  Jonathan M Cordeiro; Guillermo J Perez; Nicole Schmitt; Ryan Pfeiffer; Vladislav V Nesterenko; Elena Burashnikov; Christian Veltmann; Martin Borggrefe; Christian Wolpert; Rainer Schimpf; Charles Antzelevitch
Journal:  Can J Physiol Pharmacol       Date:  2010-12       Impact factor: 2.273

Review 3.  Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Yongfei Song; Zequn Zheng; Jiangfang Lian
Journal:  Front Cardiovasc Med       Date:  2022-05-13

4.  Novel mechanisms of trafficking defect caused by KCNQ1 mutations found in long QT syndrome.

Authors:  Akinori Sato; Takuro Arimura; Naomasa Makita; Taisuke Ishikawa; Yoshiyasu Aizawa; Hiroya Ushinohama; Yoshifusa Aizawa; Akinori Kimura
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

5.  Mechanisms of beta-adrenergic modulation of I(Ks) in the guinea-pig ventricle: insights from experimental and model-based analysis.

Authors:  Stefano Severi; Cristiana Corsi; Marcella Rocchetti; Antonio Zaza
Journal:  Biophys J       Date:  2009-05-06       Impact factor: 4.033

Review 6.  Uses of cardiomyocytes generated from induced pluripotent stem cells.

Authors:  Tung-Ying Lu; Lei Yang
Journal:  Stem Cell Res Ther       Date:  2011-11-18       Impact factor: 6.832

Review 7.  Genetics of channelopathies associated with sudden cardiac death.

Authors:  Oscar Campuzano; Georgia Sarquella-Brugada; Ramon Brugada; Josep Brugada
Journal:  Glob Cardiol Sci Pract       Date:  2015-10-13

8.  Retroinverso analogs of spadin display increased antidepressant effects.

Authors:  Julie Veyssiere; Hamid Moha Ou Maati; Jean Mazella; Georges Gaudriault; Sébastien Moreno; Catherine Heurteaux; Marc Borsotto
Journal:  Psychopharmacology (Berl)       Date:  2014-08-02       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.